Thank you very much for your contribution
The online abstract portal for the Melanoma and ImmunoTherapy Bridge is closed now. The abstracts are being anonymously reviewed by the scientific committee. Authors will receive notifications of acceptance by beginning of October 2017
The accepted abstract which have not been published elsewhere will be included in a dedicated Supplement of the Journal of Translational Medicine.
For information please contact email@example.com